PREVIEW
OF YOUR NEWS WIDGETHigh blood pressure news and high blood pressure widget
Saturday, November 15, 2008 ( change date )
Rasilez®, First-in-class Direct Renin Inhibitor, Provides Greater Reduction In High Blood Pressure Than ACE Inhibitor Ramipril
New clinical data presented show first-in-class direct renin inhibitor Rasilez® (aliskiren), known as Tekturna® in the US, provides significantly greater blood pressure reductions in patients with high blood pressure aged 65 and over, compared to the angiotensin-converting enzyme (ACE) inhibitor ramipril[1].
Medicalnewstoday.com Saturday, November 15, 2008
INSTALL YOUR WIDGET